The metabolism of halothane during and after anaesthesia was studied in eight patients of different age and body weight by estimating the concentration of halothane and one of its metabolites (bromide) in the blood. A gas chromatograph with an electron capture detector was used to estimate halothane, while blood bromide levels were measured by neutron activation analysis. There was an initial burst of bromide production during 20 minutes of halothane administration. Bromide levels then fell, but not to control levels, and remained so until the recovery of the patient from anaesthesia. In the postanaesthetic period, bromide production took place on a larger scale than before.
The metabolism of halothane during and after anaesthesia was studied in eight patients of different age and body weight by estimating the concentration of halothane and one of its metabolites (bromide) in the blood. A gas chromatograph with an electron capture detector was used to estimate halothane, while blood bromide levels were measured by neutron activation analysis. There was an initial burst of bromide production during 20 minutes of halothane administration. Bromide levels then fell, but not to control levels, and remained so until the recovery of the patient from anaesthesia. In the postanaesthetic period, bromide production took place on a larger scale than before.
It is now generally accepted that halothane is metabolized, both in animals (Van Dyke, Chenoweth and Van Poznak, 1964; Cohen, 1969; Cohen and Hood, 1969) and in man (Cascorbi, Blake and Helrich, 1970) . "In-vivo" studies have confirmed that dehalogenation takes place and that non-volatile 14 C metabolites are excreted in the urine.
Metabolic studies of halothane in humans have been concentrated on measuring excretion products in urine or other excreta. Since the intermediates of halothane metabolism are not known, it is difficult to plot the time course of metabolism during anaesthesia. As each halothane molecule contains one atom of bromine, the blood bromide level should give a guide to the time and extent of halothane breakdown since debromination is known to occur (Rehder et al., 1967) .
The present report correlates blood levels of bromide with the simultaneous determination of blood levels of halothane during and after halothane anaesthesia.
METHOD

Clinical studies.
A preliminary study was carried out in a male patient aged 72 years given halothane anaesthesia for 2\ hr for plastic surgery to the hand. Induction was achieved with thiopentone 250 mg and anaesthesia maintained using nitrous oxide (5 l./min), oxygen (2 l./min) and halothane \\% for 30 min. During the remaining 2 hr 1 %< halothane was used. A preoperative blood sample was taken for bromide estimation. During anaesthesia venous blood samples were then taken at 10, 30, 60 and 150 min from the start of anaesthesia. In the postoperative period samples of blood were taken at 4 and 7i hr as calculated from the beginning of anaesthesia.
Following analysis of these samples further studies were carried out on eight patients of different age and body weight. These patients were undergoing minor gynaecological operations and all received thiopentone, nitrous oxide, oxygen and 1£% halothane for 20 min. A preoperative blood sample was taken for the estimation of blood bromide. A further blood sample was taken when the halothane was turned off at the end of the 20-min period of anaesthesia. Respiration was spontaneous in all cases. A sample of blood was taken on recovery of consciousness as determined by response to commands. Further blood samples were taken at 1, 3, 7, 20 and 44 hr, as calculated from the beginning of anaesthesia. The samples were assayed for halothane and whole Mood bromide content.
The respiratory efficiency of each patient was assessed by performing two pulmonary function tests. The forced expiratory volume (FEV,) and the forced vital capacity (FVQ. Table I shows the age, body weight, and respiratory efficiency of the eight female patients.
Volunteer studies.
Sodium bromide was administered by intravenous injection in conscious volunteers to study the rate of disappearance of bromide from the blood. In two volunteers 100 mg of bromide was slowly injected over a period of 20 min. In two further volunteers 200 mg of bromide in isotonic glucose was infused M. M. ATAIXAH,* MJ).; I. C. GEDDES, MJJ., F.F.A.R-OS.;
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•Present address: Department of Anaesthesia, Mansoura Faculty of Medicine, Mansoura, Egypt. by intravenous drip over a period of 1 hr. Blood samples were taken from the opposite arm before, during and after administration to determine blood bromide concentrations.
Laboratory methods. Determination of bromide in blood.
A method of neutron activation analysis originally described by Bowen (1959) and Belkas and Souliotis (1966) was used in this study. Blood samples and a standard concentration of bromide (control) were irradiated and subjected with a known weight of bromide (carrier) to chemical separation and precipitated as silver bromide. Radioactivity in these precipitates was counted and the concentrations of bromide in the samples calculated by comparing the counts of the samples with those of the control. In duplicate samples of blood at varying concentrations of bromide the mean difference was 4.5% ±1.95 and the mean of the SD of twelve duplicate estimations was ± 0.87. The 95 % confidence limits of a single estimation was ±1.6% (Atallah and Geddes, 1973) .
Quantitative estimation of hahthane in blood. This technique has already been described in full (Atallah and Geddes, 1972) . A Perkin Elmer Fll gas chromatograph with an electron capture detector was used. Halothane was extracted from blood samples by nheptane, as originally described by Butler and Hill (1961) . One /xl of this extract was placed on a column containing 15% silicon fluid MS55O as stationary phase on Universal B.60-80 mesh. The mean recovery of halothane from blood, in the range 7.10-36.13 mg/100 ml, was 96.98% ±2.27. The mean of the standard deviations of duplicate extractions was ± 0.87. With low blood halothane concentrations, 112.54-323.00 /ug/100 ml, the mean per cent recovery was 107.41 ± 5.18 and the mean of the standard deviations of duplicate extractions was ±2.89.
Pilot study.
RESULTS
halothane anaesthetic the blood bromide concentrations rose from the preoperative value of 8.3 /ig/ml to a TnaviTnnm of 11.7 jug/ml at 60 min ( fig. 1 , table LI). No further rise occurred until the end of the 2i-hr anaesthetic. Samples taken 4 and 1\ hr after induction of anaesthesia showed evidence of a further rise in circulating bromide levels. These findings suggested that debromination took place early in anaesthesia and again following recovery from anaesthesia. No data concerning blood halothane levels were obtained.
Studies in eight patients.
Blood bromide. The administration of halothane 1£% for 20. min was associated with a definite rise in blood bromide (table HI, fig. 2 ). In the follow- ing 10 min the blood bromide level fell in all but one patient examined at this time. At 1 hr after induction of anaesthesia four patients showed a rise of blood bromide above the level observed at 30 min. By 3 hr in all patients there was a further elevation of blood bromide suggesting that there was now active debromination of halothane taking place. This rise continued to a greater or lesser degree at 7 and 20 hr in all patients. By 44 hr little further rise in blood bromide was observed.
Blood halothane. The venous halothane concentrations at the end of 20 min of halothane anaesthesia were in die range 7600-10,650 /*g/100 ml (table IV) . At the time of recovery from anaesthesia there was less variation in the blood halothane concentration between patients (2200-3000 /ig/100 ml). Halothane in trace amounts could still be identified in venous blood 44 hr after induction of anaesthesia.
Volunteer studies.
The rate of disappearance of bromide from the blood of two volunteers, following intravenous administration of 100 mg of bromide given during 20 min is shown in figure 3 and table V. There was an increase in the blood bromide above the preadministration level. A rapid fall took place in the first 10 min after completion of infusion and this then slowly decreased over the observed period. The over the period of administration and the blood bromide level slowly decreased during the period of blood sampling.
DISCUSSION
The possible patiiways of metabolism of halothane are given in figure 5 . Trifluoroacetic acid is a known metabolite excreted in the urine (Stier, 1964; Stier and Alter, 1966) . This end-product of halodiane metabolism has been supposed to be formed either through trifluoroethanol (Van Dyke and Chenowedi, 1965b) , through a labile ionized intermediate compound (Stier, 1968) or through trifluoroacetaldehyde by the oxidation reduction systems of the body as has been suggested by Otani (Airaksinen, 1968 The bond energies of the atoms of halothane are given in table VII. The highest bond energy is between fluorine and carbon. This explains why the trifluoride part of the molecule is not affected by Van Dyke and Chenowedi, 1965a) . Bromine and chlorine are less tighdy bound and are more readily removed. For each molecule of halodiane metabolized one bromine atom is produced (Stier, 1968) .
Distribution of bromide in the body.
Bromide has been found to have a partition in die body similar to that of chloride. The rate of passage of bromides through capillary walls is nearly equal to that of chloride (Harm and Hevesy, 1940) . Following injection, bromide passes rapidly into die tissues, and mainly into the extracellular fluid, but only slowly into the brain and cerebrospinal fluid (Sb'remark, 1960a) . Excretion of bromide is slow and mainly renal (Ucko, 1936) . Bodansky and Modell (1941) in dogs, injected a large dose of bromide intravenously and found diat 0.6% was excreted in die urine in die first hour. Soremark, (1960b) , using "Br reported that die biological half-life of bromide ions in human blood was 12 days.
In die human volunteers die blood bromide level rose during the period of administration of sodium bromide. At die end of eidier 20 min or die 1-hr infusion, die blood bromide level began to fall. There was an initial rapid fall suggesting a phase of early redistribution followed by a slower rate of fall indicating saturation of a body compartment. In all the anaesthetized patients, mere was an initial rise of blood bromide similar to that seen when bromide was administered by intravenous infusion. This suggested that active metabolism of halodiane was taking place widi liberation of bromide. At the end of administration of halodiane there was a fall in die level of circulating blood bromide presumably due to a discrepancy between die rate of production of bromide and the factors responsible for its disappearance from the blood.
In the volunteers who received 100 mg of bromide in 20 min the blood bromide level fell in a manner similar to die mean concentration of bromide seen in die eight patients after 20 min of halodiane anaesthesia ( fig. 2 ). In these patients litde or no production of bromide took place immediately after halothane administration but bromide release continued for some 44 hours.
Blood halothane concentrations.
An attempt was made to relate die blood halodiane level with the presence or absence of die production of bromide. In table IV die blood bromide increase above the preanaesdietic level is tabulated with die blood halothane concentration. In samples taken 1 hr after anaesthesia there was a slight increase in the bromide concentration above that observed at 30 min in four patients (D, E, F, and H), while in the remaining three patients (C, G, and J) there was no appreciable increase in the blood bromide. In the latter three patients the blood halothane concentration was higher than in the previous four patients. When the halodiane concentration fell in these three patients a small rise in the blood bromide level was then observed.
Suppression of halothane metabolism with increasing blood concentrations has been reported by Cascorbi, Blake and Helrich (1970) . These authors administered trace doses of 14 C-labelled halothane to two volunteers in the absence and presence of anaesthetic concentrations of halothane. They reported that less radioactive urinary metabolites were recovered following halothane anaesthesia. Sawyer and bis colleagues (1971) , in animal studies using Hormel miniature swine found that the fraction of halothane removed from blood by the liver increased as halothane concentration fell. They attributed this to eidier microsomal enzyme saturation or possibly complete suppression of metabolism by halothane at anaesthetic concentrations. Brown (1971) , studied the influence of halothane in the in-vitro biotransformation of a variety of drugs by hepatic mixed function oxidase enzymes of the rat's liver. He found that halothane diminished the rate of oxidation of hexobarbitone, amylobarbitone and pentobarbitone, and the demethylation of aminopyrine. This inhibition was dose-dependent and reversible. Our findings suggest that halothane at anaesthetic concentrations, also inhibits its own dehalogenation, and that this is reversed as the blood concentration fails. 
RESUMEN
Se estudi6 el metabolismo del halothane durante y despues de la anestesia en ocho enfermos de diferente edad y peso, determinando la concentraci6n de halothane y de uno de sus m:tabolitos (bromuro) en la sangre. Para determinar el halothane se empleo un cromatografo de gas con un detector de captacion electr6nico, mientras que los niveles de bromuro en sangre fueron medidos por anilisis de activaci6n de neutrones. Habia un aumento inicial de la producci6n de bromuro durante 20 minutos de laadministraci6n de halothane. Los niveles de bromuro caian despufa, pero no hasta los valores de control, permaneciendo asi hasta la recuperaci6n del enfermo de la anestesia. En el periodo postanestfaico, la production de bromuro tiene lugar en una mayor escala que antes.
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